This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Istituto Superiore Di Sanita, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Universita Degli Studi Di Urbino. Active years: 2010-2018.
Company Filing History:


Years Active: 2010-2018
Title: The Innovative Contributions of Barbara Ensoli
Introduction
Barbara Ensoli, a prominent inventor based in Rome, Italy, has made significant strides in the field of biomedical research. With a total of nine patents to her name, her innovative work has focused primarily on the development of novel therapeutic approaches to combat viral infections, particularly HIV.
Latest Patents
Among her latest contributions are patents related to "Tat complexes and vaccines comprising them," where she explores complexes that incorporate HIV Tat and the V3 loop from gp120 Env. This invention aims to provide novel epitopes that can be immunogenic, thereby preventing or inhibiting infection by HIV. Furthermore, she has developed "Replication-competent adenoviral vectors," which offer improved platforms for high-level transgene expression, suitable for various therapeutic and prophylactic applications.
Career Highlights
Barbara has worked for notable organizations, including the Istituto Superiore di Sanità and the Government of the United States, representing the Secretary of the Department of Health and Human Services. Her extensive experience in these institutions has significantly influenced her research and innovation trajectory.
Collaborations
Throughout her career, Barbara has collaborated with distinguished colleagues such as Bo Peng and Rebecca Voltan. These partnerships have not only enriched her research but have also facilitated the advancement of critical scientific understanding regarding HIV and viral treatment methodologies.
Conclusion
Barbara Ensoli’s innovative patents and collaborations underscore her significant contributions to the field of biomedical research. Her dedication to developing effective treatments highlights the importance of continuous innovation in addressing global health challenges.